{"transactions":[{"id":706650,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-18T01:54:51.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":4406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each restricted stock unit (\"RSU\") will be settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."}],"balance_after":46749,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4406},"source":{"system":"sec-edgar","filing":"0001104659-26-084774","document":"tm2620763-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465926084774/tm2620763-1_4seq1.xml","form_type":"4"}},{"id":748729,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:24:55.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":59701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":157142,"source":{"system":"sec-edgar","filing":"0001237253-26-000004","document":"wk-form4_1780691093.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000123725326000004/wk-form4_1780691093.xml","form_type":"4"}},{"id":749399,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:11:01.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":false,"shares":2685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs, which were granted on August 14, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs, which were granted on August 14, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."}],"balance_after":42343,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2685},"source":{"system":"sec-edgar","filing":"0001104659-26-070520","document":"tm2616870-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465926070520/tm2616870-3_4seq1.xml","form_type":"4"}},{"id":749398,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:11:01.000Z","date":"2026-06-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2197,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Reporting Person entered into an agreement with the Issuer pursuant to which the Reporting Person forfeited the right to receive 2,197 RSUs that would otherwise have vested in exchange for a payment from the Issuer to facilitate the Reporting Person's ability to satisfy certain tax obligations related to the RSUs scheduled to vest."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The number of RSUs forfeited is based on a percentage."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs, which were granted on August 14, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs, which were granted on August 14, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."}],"balance_after":45028,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2197},"source":{"system":"sec-edgar","filing":"0001104659-26-070520","document":"tm2616870-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465926070520/tm2616870-3_4seq1.xml","form_type":"4"}},{"id":749397,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-04T20:11:01.000Z","date":"2026-06-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":619,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The number of ordinary shares withheld to satisfy tax withholding obligations arising out the vesting of RSUs is based on a percentage and did not take into account any market value as the Issuer's ordinary shares are not listed or quoted on a recognized trading market."}],"balance_after":6244,"source":{"system":"sec-edgar","filing":"0001104659-26-070520","document":"tm2616870-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465926070520/tm2616870-3_4seq1.xml","form_type":"4"}},{"id":749396,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-04T20:11:01.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":true,"shares":2685,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the Issuer at one share per RSU."}],"balance_after":6863,"source":{"system":"sec-edgar","filing":"0001104659-26-070520","document":"tm2616870-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465926070520/tm2616870-3_4seq1.xml","form_type":"4"}},{"id":779869,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T21:16:45.000Z","date":"2026-05-14","kind":"purchase","planned":false,"acquired":true,"shares":7500,"price":3.685,"value":27637.5,"ownership":{"direct":true},"balance_after":97441,"source":{"system":"sec-edgar","filing":"0001237253-26-000002","document":"wk-form4_1778793403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000123725326000002/wk-form4_1778793403.xml","form_type":"4"}},{"id":780627,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-13T20:35:16.000Z","date":"2026-05-13","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":75.875,"value":151750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Price reported in Table I, Column 4 is the price at which these shares were purchased in a single transaction."}],"balance_after":27862,"source":{"system":"sec-edgar","filing":"0001628280-26-034642","document":"wk-form4_1778704514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000162828026034642/wk-form4_1778704514.xml","form_type":"4"}},{"id":881728,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-02-26T01:45:34.000Z","date":"2026-02-23","kind":"grant","planned":false,"acquired":true,"shares":3984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each restricted stock unit (\"RSU\") will be settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each RSU will fully vest on February 23, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each RSU will fully vest on February 23, 2027."}],"balance_after":47225,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3984},"source":{"system":"sec-edgar","filing":"0001104659-26-019921","document":"tm267115-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465926019921/tm267115-1_4seq1.xml","form_type":"4"}},{"id":887715,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-02-23T21:30:19.000Z","date":"2026-02-19","kind":"exercise","planned":false,"acquired":false,"shares":1619.3325,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU vests and is settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 19, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1619.3325},"source":{"system":"sec-edgar","filing":"0001628280-26-010671","document":"wk-form4_1771882216.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000162828026010671/wk-form4_1771882216.xml","form_type":"4"}},{"id":887714,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-23T21:30:19.000Z","date":"2026-02-19","kind":"exercise","planned":false,"acquired":true,"shares":1619,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."}],"balance_after":25862,"source":{"system":"sec-edgar","filing":"0001628280-26-010671","document":"wk-form4_1771882216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000162828026010671/wk-form4_1771882216.xml","form_type":"4"}},{"id":892963,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-02-20T01:54:13.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":1936,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":1936,"derivative":{"underlying":"Common Stock","underlying_shares":1936},"source":{"system":"sec-edgar","filing":"0001628280-26-009978","document":"wk-form4_1771552449.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000162828026009978/wk-form4_1771552449.xml","form_type":"4"}},{"id":950662,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-01-05T23:00:23.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":false,"shares":3014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 19, 2024, the Reporting Person was granted 13,678 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024. Outstanding RSUs were subsequently adjusted as described in footnote 6 below."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 19, 2024, the Reporting Person was granted 13,678 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024. Outstanding RSUs were subsequently adjusted as described in footnote 6 below."}],"balance_after":43241,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3014},"source":{"system":"sec-edgar","filing":"0001104659-26-000777","document":"tm261751-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465926000777/tm261751-1_4seq1.xml","form_type":"4"}},{"id":950661,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-01-05T23:00:23.000Z","date":"2026-01-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2466,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Reporting Person entered into an agreement with the Issuer pursuant to which the Reporting Person forfeited the right to receive 2,466 RSUs that would otherwise have vested in exchange for a payment from the Issuer to facilitate the Reporting Person's ability to satisfy certain tax obligations related to the RSUs scheduled to vest."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The number of RSUs forfeited is based on a percentage."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 19, 2024, the Reporting Person was granted 13,678 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024. Outstanding RSUs were subsequently adjusted as described in footnote 6 below."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 19, 2024, the Reporting Person was granted 13,678 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024. Outstanding RSUs were subsequently adjusted as described in footnote 6 below."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Reflects that the Reporting Person received 8,183 additional RSUs resulting from the adjustment of the RSUs held by the Reporting Person immediately prior to the separation of Par Health, Inc. (\"Par Health\") from the Issuer on November 10, 2025, pursuant to the terms of the Employee Matters Agreement by and between the Issuer and Par Health."}],"balance_after":46255,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2466},"source":{"system":"sec-edgar","filing":"0001104659-26-000777","document":"tm261751-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465926000777/tm261751-1_4seq1.xml","form_type":"4"}},{"id":950660,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-01-05T23:00:23.000Z","date":"2026-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":854,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The number of ordinary shares withheld to satisfy tax withholding obligations arising out the vesting of RSUs is based on a percentage and did not take into account any market value as the Issuer's ordinary shares are not listed or quoted on a recognized trading market."}],"balance_after":4178,"source":{"system":"sec-edgar","filing":"0001104659-26-000777","document":"tm261751-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465926000777/tm261751-1_4seq1.xml","form_type":"4"}},{"id":950659,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-01-05T23:00:23.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":true,"shares":3014,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the Issuer at one share per RSU."}],"balance_after":5032,"source":{"system":"sec-edgar","filing":"0001104659-26-000777","document":"tm261751-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465926000777/tm261751-1_4seq1.xml","form_type":"4"}},{"id":1063775,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-08-19T01:00:14.000Z","date":"2025-08-14","kind":"grant","planned":false,"acquired":true,"shares":4062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each restricted stock unit (\"RSU\") will be settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."}],"balance_after":40538,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4062},"source":{"system":"sec-edgar","filing":"0001104659-25-079941","document":"tm2523680-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465925079941/tm2523680-1_4seq1.xml","form_type":"4"}},{"id":1076146,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-08-05T00:48:18.000Z","date":"2025-07-31","kind":"grant","planned":false,"acquired":true,"shares":27357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 31, 2025, pursuant to the Transaction Agreement, dated as of March 13, 2025 (as amended, the \"Transaction Agreement\"), by and among Mallinckrodt plc (the \"Issuer\"), Endo, Inc. (\"Endo\") and Salvare Merger Sub LLC, the Issuer's wholly owned subsidiary (\"Merger Sub\"), the Merger Sub merged with and into Endo (the \"Business Combination\"), with Endo surviving the Business Combination as a wholly owned subsidiary of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon consummation of the Business Combination, each performance unit (\"PSU\") held by the reporting person automatically converted into a restricted unit (\"RSU\"). Each RSU will fully vest on December 25, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Upon consummation of the Business Combination, each performance unit (\"PSU\") held by the reporting person automatically converted into a restricted unit (\"RSU\"). Each RSU will fully vest on December 25, 2026."}],"balance_after":36476,"derivative":{"underlying":"Ordinary Shares","underlying_shares":27357},"source":{"system":"sec-edgar","filing":"0001104659-25-073785","document":"tm2522414-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465925073785/tm2522414-11_4seq1.xml","form_type":"4"}},{"id":1120395,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T20:05:39.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":49796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":89941,"source":{"system":"sec-edgar","filing":"0001628280-25-029979","document":"wk-form4_1749240326.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025029979/wk-form4_1749240326.xml","form_type":"4"}},{"id":1255332,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-02-20T21:21:39.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":1596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":1596,"derivative":{"underlying":"Common Stock","underlying_shares":1596},"source":{"system":"sec-edgar","filing":"0001555280-25-000123","document":"wk-form4_1740086492.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528025000123/wk-form4_1740086492.xml","form_type":"4"}},{"id":1273614,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-02-11T22:14:30.000Z","date":"2025-02-08","kind":"exercise","planned":false,"acquired":false,"shares":1225.4023,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU vests and is settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, February 8, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1225.4023},"source":{"system":"sec-edgar","filing":"0001555280-25-000090","document":"wk-form4_1739312064.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528025000090/wk-form4_1739312064.xml","form_type":"4"}},{"id":1273613,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-11T22:14:30.000Z","date":"2025-02-08","kind":"exercise","planned":false,"acquired":true,"shares":1225,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."}],"balance_after":24243,"source":{"system":"sec-edgar","filing":"0001555280-25-000090","document":"wk-form4_1739312064.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528025000090/wk-form4_1739312064.xml","form_type":"4"}},{"id":1276343,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T14:24:29.000Z","date":"2025-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1236.2125,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU vests and is settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 6, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1236.2125},"source":{"system":"sec-edgar","filing":"0001555280-25-000042","document":"wk-form4_1739197461.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528025000042/wk-form4_1739197461.xml","form_type":"4"}},{"id":1276342,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-10T14:24:29.000Z","date":"2025-02-06","kind":"exercise","planned":false,"acquired":true,"shares":1236,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."}],"balance_after":23018,"source":{"system":"sec-edgar","filing":"0001555280-25-000042","document":"wk-form4_1739197461.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528025000042/wk-form4_1739197461.xml","form_type":"4"}},{"id":1318443,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-02T21:59:29.000Z","date":"2025-01-01","kind":"exercise","planned":false,"acquired":false,"shares":2507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 19, 2024, the reporting person was granted 13,678 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 19, 2024, the reporting person was granted 13,678 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024."}],"balance_after":9119,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2507},"source":{"system":"sec-edgar","filing":"0001104659-25-000364","document":"tm2432211-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465925000364/tm2432211-1_4seq1.xml","form_type":"4"}},{"id":1318442,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-02T21:59:29.000Z","date":"2025-01-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2052,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The reporting person entered into an agreement with the issuer pursuant to which the reporting person forfeited the right to receive 2,052 RSUs that would otherwise have vested in exchange for a payment from the issuer to facilitate the reporting person's ability to satisfy certain tax obligations related to the RSUs scheduled to vest."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The number of RSUs forfeited is based on a percentage."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 19, 2024, the reporting person was granted 13,678 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 19, 2024, the reporting person was granted 13,678 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024."}],"balance_after":11626,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2052},"source":{"system":"sec-edgar","filing":"0001104659-25-000364","document":"tm2432211-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465925000364/tm2432211-1_4seq1.xml","form_type":"4"}},{"id":1318441,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-01-02T21:59:29.000Z","date":"2025-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":489,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The number of ordinary shares withheld to satisfy tax withholding obligations arising out the vesting of RSUs is based on a percentage and did not take into account any market value as the issuer's ordinary shares are not listed or quoted on a recognized trading market."}],"balance_after":2018,"source":{"system":"sec-edgar","filing":"0001104659-25-000364","document":"tm2432211-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465925000364/tm2432211-1_4seq1.xml","form_type":"4"}},{"id":1318440,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-01-02T21:59:29.000Z","date":"2025-01-01","kind":"exercise","planned":false,"acquired":true,"shares":2507,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the issuer at one share per RSU."}],"balance_after":2507,"source":{"system":"sec-edgar","filing":"0001104659-25-000364","document":"tm2432211-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465925000364/tm2432211-1_4seq1.xml","form_type":"4"}},{"id":1487587,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T20:53:41.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":15695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":40145,"source":{"system":"sec-edgar","filing":"0001628280-24-027328","document":"wk-form4_1717793613.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024027328/wk-form4_1717793613.xml","form_type":"4"}},{"id":1633164,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-20T21:09:00.000Z","date":"2024-02-19","kind":"grant","planned":false,"acquired":false,"shares":13678,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each restricted stock unit (the \"RSU\") will be settled in ordinary shares of the issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest ratably on each of the first three anniversaries of January 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest ratably on each of the first three anniversaries of January 1, 2024."}],"balance_after":13678,"derivative":{"underlying":"Ordinary Shares","underlying_shares":13678},"source":{"system":"sec-edgar","filing":"0001104659-24-025515","document":"tm245307-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465924025515/tm245307-5_4seq1.xml","form_type":"4"}},{"id":1645778,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-02-13T22:13:42.000Z","date":"2024-02-10","kind":"exercise","planned":false,"acquired":false,"shares":1463.3937,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. The RSUs vest as follows: 1,463.3937 RSUs vested on February 10, 2024; and 1,212.3053 RSUs will vest on February 8, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, February 8, 2022; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events."}],"balance_after":1212.3053,"derivative":{"underlying":"Common Stock","underlying_shares":1463.3937},"source":{"system":"sec-edgar","filing":"0001555280-24-000179","document":"wk-form4_1707862406.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528024000179/wk-form4_1707862406.xml","form_type":"4"}},{"id":1645777,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-13T22:13:42.000Z","date":"2024-02-10","kind":"exercise","planned":false,"acquired":true,"shares":1463,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."}],"balance_after":21782,"source":{"system":"sec-edgar","filing":"0001555280-24-000179","document":"wk-form4_1707862406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528024000179/wk-form4_1707862406.xml","form_type":"4"}},{"id":1648974,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-02-12T22:57:28.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":1493.2652,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 8, 2023; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1493.2652},"source":{"system":"sec-edgar","filing":"0001555280-24-000137","document":"wk-form4_1707778638.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528024000137/wk-form4_1707778638.xml","form_type":"4"}},{"id":1648973,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-12T22:57:28.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":true,"shares":1493,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."}],"balance_after":20319,"source":{"system":"sec-edgar","filing":"0001555280-24-000137","document":"wk-form4_1707778638.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528024000137/wk-form4_1707778638.xml","form_type":"4"}},{"id":1653216,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-02-08T21:35:28.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":1223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":1223,"derivative":{"underlying":"Common Stock","underlying_shares":1223},"source":{"system":"sec-edgar","filing":"0001555280-24-000083","document":"wk-form4_1707428117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528024000083/wk-form4_1707428117.xml","form_type":"4"}},{"id":1738840,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-11-16T21:11:05.000Z","date":"2023-11-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":32048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 28, 2023, Mallinckrodt plc (the \"Company\") and certain of its subsidiaries voluntarily initiated proceedings under chapter 11 of title 11 of the United States Code in the U.S. Bankruptcy Court for the District of Delaware (the \"Bankruptcy Court\"). On September 20, 2023, the Company's directors presented a petition before the High Court of Ireland (the \"Irish High Court\") seeking the appointment of an examiner (the \"Examiner\") to the Company, thereby commencing examinership proceedings with respect to the Company in Ireland."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 10, 2023, the Bankruptcy Court entered an order confirming the First Amended Prepackaged Joint Chapter 11 Plan of Reorganization of Mallinckrodt Plc and Its Debtor Affiliates (as may be amended or supplemented from time to time in accordance with its terms, the \"Plan\"). On November 10, 2023, the Irish High Court made an order confirming a scheme of arrangement proposed by the Examiner that is based on and consistent in all respects with the Plan (the \"Scheme\"). On November 14, 2023 (the \"Effective Date\"), the Plan and the Scheme became effective and the Company emerged from bankruptcy."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On the Effective Date, all of the Company's previously outstanding ordinary shares (the \"Ordinary Shares\"), including options, warrants, rights, restricted stock units or other securities or agreements to acquire such Ordinary Shares, were cancelled and extinguished pursuant to the Plan and the Scheme. In connection with emergence, the reporting person ceased to be a Section 16 reporting person. This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-23-119105","document":"tm2330745-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465923119105/tm2330745-2_4seq1.xml","form_type":"4"}},{"id":1841912,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-29T22:51:25.000Z","date":"2023-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":39083,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (the \"RSUs\") granted to the reporting person on January 3, 2023 were canceled by mutual agreement of the reporting person and Mallinckrodt plc (\"Mallinckrodt\") in connection with the Board of Directors (the \"Board\") of Mallinckrodt's approval of changes to the compensation of non-employee members of the Board (such changes, the \"Compensation Changes\"). In connection with the Compensation Changes, and in consideration of the cancelation of the RSUs, the reporting person will receive (i) in the event of a bankruptcy filing, additional cash compensation for 2023 of $279,000 or (ii) in the absence of a bankruptcy filing, additional cash compensation for 2023 of $325,500. In either event, the amounts are to be prepaid pro rata on a quarterly basis and paid in arrears for the prior quarters of fiscal year 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units (the \"RSUs\") granted to the reporting person on January 3, 2023 were canceled by mutual agreement of the reporting person and Mallinckrodt plc (\"Mallinckrodt\") in connection with the Board of Directors (the \"Board\") of Mallinckrodt's approval of changes to the compensation of non-employee members of the Board (such changes, the \"Compensation Changes\"). In connection with the Compensation Changes, and in consideration of the cancelation of the RSUs, the reporting person will receive (i) in the event of a bankruptcy filing, additional cash compensation for 2023 of $279,000 or (ii) in the absence of a bankruptcy filing, additional cash compensation for 2023 of $325,500. In either event, the amounts are to be prepaid pro rata on a quarterly basis and paid in arrears for the prior quarters of fiscal year 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The restricted stock units (the \"RSUs\") granted to the reporting person on January 3, 2023 were canceled by mutual agreement of the reporting person and Mallinckrodt plc (\"Mallinckrodt\") in connection with the Board of Directors (the \"Board\") of Mallinckrodt's approval of changes to the compensation of non-employee members of the Board (such changes, the \"Compensation Changes\"). In connection with the Compensation Changes, and in consideration of the cancelation of the RSUs, the reporting person will receive (i) in the event of a bankruptcy filing, additional cash compensation for 2023 of $279,000 or (ii) in the absence of a bankruptcy filing, additional cash compensation for 2023 of $325,500. In either event, the amounts are to be prepaid pro rata on a quarterly basis and paid in arrears for the prior quarters of fiscal year 2023."}],"balance_after":32048,"source":{"system":"sec-edgar","filing":"0001104659-23-076467","document":"tm2320181-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465923076467/tm2320181-1_4seq1.xml","form_type":"4"}},{"id":1841911,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-29T22:51:25.000Z","date":"2023-06-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":3689,"price":1.28,"value":4721.92,"ownership":{"direct":true},"balance_after":71131,"source":{"system":"sec-edgar","filing":"0001104659-23-076467","document":"tm2320181-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465923076467/tm2320181-1_4seq1.xml","form_type":"4"}},{"id":1870921,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T22:21:40.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":7575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":24450,"source":{"system":"sec-edgar","filing":"0001628280-23-020715","document":"wk-form4_1685744491.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828023020715/wk-form4_1685744491.xml","form_type":"4"}},{"id":1949834,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-03-16T20:05:24.000Z","date":"2023-03-14","kind":"purchase","acquired":true,"shares":5000,"price":8.4659,"value":42329.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.3622 to $8.5000, inclusive. The reporting person undertakes to provide to Mallinckrodt plc, any security holder of Mallinckrodt plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1."}],"balance_after":74820,"source":{"system":"sec-edgar","filing":"0001104659-23-033301","document":"tm239775-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465923033301/tm239775-1_4seq1.xml","form_type":"4"}},{"id":2015663,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-02-14T21:46:34.000Z","date":"2023-02-11","kind":"exercise","acquired":false,"shares":1626.8438,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 1,450.3939 RSUs will vest on February 10, 2024; and 1,201.5360 RSUs will vest on February 8, 2025."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 1,450.3939 RSUs will vest on February 10, 2024; and 1,201.5360 RSUs will vest on February 8, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 1,450.3939 RSUs will vest on February 10, 2024; and 1,201.5360 RSUs will vest on February 8, 2025."}],"balance_after":2651.9299,"derivative":{"underlying":"Common Stock","underlying_shares":1626.8438},"source":{"system":"sec-edgar","filing":"0001555280-23-000091","document":"wf-form4_167641114982160.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528023000091/wf-form4_167641114982160.xml","form_type":"4"}},{"id":2015662,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-14T21:46:34.000Z","date":"2023-02-11","kind":"exercise","acquired":true,"shares":1626,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."}],"balance_after":18826,"source":{"system":"sec-edgar","filing":"0001555280-23-000091","document":"wf-form4_167641114982160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528023000091/wf-form4_167641114982160.xml","form_type":"4"}},{"id":2022431,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-02-10T23:24:47.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":1480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated  2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). RSUs vest and are settled in shares of Zoetis common stock on the first anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":1480,"derivative":{"underlying":"Common Stock","underlying_shares":1480},"source":{"system":"sec-edgar","filing":"0001555280-23-000049","document":"wf-form4_167607147269070.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528023000049/wf-form4_167607147269070.xml","form_type":"4"}},{"id":2062110,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-01-05T23:03:16.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":39083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported ordinary shares represent restricted stock units (\"RSUs\"), which will be settled in an equal number of MNK ordinary shares and will vest ratably on each of the first two anniversaries of MNK's emergence from Chapter 11 proceedings on June 16, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person has reported prior awards of RSUs in Table II of Form 4. The total reported in Column 5 includes the 39,083 newly awarded RSUs and 30,737 RSUs previously reported in Table II."}],"balance_after":69820,"source":{"system":"sec-edgar","filing":"0001104659-23-001546","document":"tm231710-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465923001546/tm231710-7_4seq1.xml","form_type":"4"}},{"id":2128882,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-01T20:31:18.000Z","date":"2022-10-31","kind":"grant","acquired":true,"shares":16875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant."}],"balance_after":16875,"source":{"system":"sec-edgar","filing":"0001628280-22-027577","document":"wf-form4_166733465434274.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022027577/wf-form4_166733465434274.xml","form_type":"4"}},{"id":2148453,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-10-03T22:40:15.000Z","date":"2022-09-29","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of the Issuer.  The RSU's will vest on September 29, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of the Issuer.  The RSU's will vest on September 29, 2023."}],"balance_after":5000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-051952","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000120919122051952/doc4.xml","form_type":"4"}},{"id":2159214,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-09-15T01:13:07.000Z","date":"2022-08-16","kind":"disposition_to_issuer","acquired":false,"shares":44354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As previously disclosed, on August 16, 2022, Paul M. Bisaro agreed to relinquish 44,354 of the restricted stock units (\"RSUs\") which were previously granted to him on July 1, 2022, with relinquishment to be applied ratably across both vesting tranches of such award, to remedy ministerial errors in computation and to correct for the fact that the RSU grant may have as a technical matter exceeded the applicable annual grant maximum amount set forth in the Mallinckrodt Pharmaceuticals 2022 Stock and Incentive Plan (the \"MIP\"). Mallinckrodt plc (\"Mallinckrodt\") has agreed that, as soon as reasonably practical following January 1, 2023, Mallinckrodt will grant to Mr. Bisaro 39,083 RSUs, subject to his continued service through such date and the MIP grant value limit, which will vest ratably on each of the first two anniversaries of emergence."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As previously disclosed, on August 16, 2022, Paul M. Bisaro agreed to relinquish 44,354 of the restricted stock units (\"RSUs\") which were previously granted to him on July 1, 2022, with relinquishment to be applied ratably across both vesting tranches of such award, to remedy ministerial errors in computation and to correct for the fact that the RSU grant may have as a technical matter exceeded the applicable annual grant maximum amount set forth in the Mallinckrodt Pharmaceuticals 2022 Stock and Incentive Plan (the \"MIP\"). Mallinckrodt plc (\"Mallinckrodt\") has agreed that, as soon as reasonably practical following January 1, 2023, Mallinckrodt will grant to Mr. Bisaro 39,083 RSUs, subject to his continued service through such date and the MIP grant value limit, which will vest ratably on each of the first two anniversaries of emergence."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As previously disclosed, on August 16, 2022, Paul M. Bisaro agreed to relinquish 44,354 of the restricted stock units (\"RSUs\") which were previously granted to him on July 1, 2022, with relinquishment to be applied ratably across both vesting tranches of such award, to remedy ministerial errors in computation and to correct for the fact that the RSU grant may have as a technical matter exceeded the applicable annual grant maximum amount set forth in the Mallinckrodt Pharmaceuticals 2022 Stock and Incentive Plan (the \"MIP\"). Mallinckrodt plc (\"Mallinckrodt\") has agreed that, as soon as reasonably practical following January 1, 2023, Mallinckrodt will grant to Mr. Bisaro 39,083 RSUs, subject to his continued service through such date and the MIP grant value limit, which will vest ratably on each of the first two anniversaries of emergence."}],"balance_after":30737,"derivative":{"underlying":"Ordinary Shares","underlying_shares":44354},"source":{"system":"sec-edgar","filing":"0001104659-22-100148","document":"tm2225913-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000110465922100148/tm2225913-1_4seq1.xml","form_type":"4"}},{"id":2177774,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-08-22T10:00:14.000Z","date":"2022-08-18","kind":"exercise","acquired":false,"shares":1984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 18, 2022, the reporting person received 1,984 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on July 1, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each RSU represents a contingent right to receive one share of issuer common stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested on July 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested on July 1, 2022."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On August 18, 2022, the reporting person received 1,984 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on July 1, 2022."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each RSU represents a contingent right to receive one share of issuer common stock upon settlement."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1984},"source":{"system":"sec-edgar","filing":"0001209191-22-046963","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000120919122046963/doc4.xml","form_type":"4"}},{"id":2177773,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-22T10:00:14.000Z","date":"2022-08-18","kind":"exercise","acquired":true,"shares":1984,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 18, 2022, the reporting person received 1,984 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on July 1, 2022."}],"balance_after":5922,"source":{"system":"sec-edgar","filing":"0001209191-22-046963","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000120919122046963/doc4.xml","form_type":"4"}},{"id":2211594,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-07-07T01:10:59.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":75091,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The grant of restricted stock units vests in equal installments on each of the first and second anniversaries of the date of Mallinckrodt plc's emergence from bankruptcy (June 16, 2022). Each restricted stock unit represents one Ordinary Share, and may be redeemed in either cash or stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant of restricted stock units vests in equal installments on each of the first and second anniversaries of the date of Mallinckrodt plc's emergence from bankruptcy (June 16, 2022). Each restricted stock unit represents one Ordinary Share, and may be redeemed in either cash or stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The grant of restricted stock units vests in equal installments on each of the first and second anniversaries of the date of Mallinckrodt plc's emergence from bankruptcy (June 16, 2022). Each restricted stock unit represents one Ordinary Share, and may be redeemed in either cash or stock."}],"balance_after":75091,"derivative":{"underlying":"Ordinary Shares","underlying_shares":75091},"source":{"system":"sec-edgar","filing":"0000899243-22-025534","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000089924322025534/doc4.xml","form_type":"4"}},{"id":2394147,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-02-16T00:53:22.000Z","date":"2022-02-12","kind":"exercise","acquired":false,"shares":2673.1237,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,673.1237 RSUs vested on February 12, 2022; 1,613.9322 RSUs will vest on February 11, 2023; 1,438.8827 RSUs will vest on February 10, 2024; and 1,192 RSUs will vest on February 8, 2025."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,673.1237 RSUs vested on February 12, 2022; 1,613.9322 RSUs will vest on February 11, 2023; 1,438.8827 RSUs will vest on February 10, 2024; and 1,192 RSUs will vest on February 8, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,673.1237 RSUs vested on February 12, 2022; 1,613.9322 RSUs will vest on February 11, 2023; 1,438.8827 RSUs will vest on February 10, 2024; and 1,192 RSUs will vest on February 8, 2025."}],"balance_after":4244.8149,"derivative":{"underlying":"Common Stock","underlying_shares":2673.1237},"source":{"system":"sec-edgar","filing":"0001555280-22-000095","document":"wf-form4_164497278680022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528022000095/wf-form4_164497278680022.xml","form_type":"4"}},{"id":2394146,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-16T00:53:22.000Z","date":"2022-02-12","kind":"exercise","acquired":true,"shares":2673,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."}],"balance_after":17200,"source":{"system":"sec-edgar","filing":"0001555280-22-000095","document":"wf-form4_164497278680022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528022000095/wf-form4_164497278680022.xml","form_type":"4"}},{"id":2404111,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-02-10T23:34:41.000Z","date":"2022-02-08","kind":"grant","acquired":true,"shares":1192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The RSUs vest as follows:  2,673.1237 RSUs will vest on February 12, 2022; 1,613.9322 RSUs will vest on February 11, 2023; 1,438.8827 RSUs will vest on February 10, 2024; and 1,192 RSUs will vest on February 8, 2025."}],"balance_after":6917.9386,"derivative":{"underlying":"Common Stock","underlying_shares":1192},"source":{"system":"sec-edgar","filing":"0001555280-22-000049","document":"wf-form4_164453606281441.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528022000049/wf-form4_164453606281441.xml","form_type":"4"}},{"id":2599138,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-18T10:03:36.000Z","date":"2021-08-16","kind":"purchase","acquired":true,"shares":50000,"price":0.79,"value":39500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions with prices ranging from $0.786 to $0.79 for an average weighted purchase price of $0.79. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":196864,"source":{"system":"sec-edgar","filing":"0001387131-21-008680","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121008680/ownership.xml","form_type":"4"}},{"id":2606318,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-08-13T01:36:36.000Z","date":"2021-08-10","kind":"exercise","acquired":false,"shares":96864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 10, 2021, the reporting person received 96,864 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on June 18, 2021."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each RSU represented a contingent right to receive one share of issuer common stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested on June 18, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested on June 18, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On August 10, 2021, the reporting person received 96,864 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on June 18, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each RSU represented a contingent right to receive one share of issuer common stock upon settlement."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":96864},"source":{"system":"sec-edgar","filing":"0001387131-21-008439","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121008439/ownership.xml","form_type":"4"}},{"id":2606317,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-13T01:36:36.000Z","date":"2021-08-10","kind":"exercise","acquired":true,"shares":96864,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 10, 2021, the reporting person received 96,864 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on June 18, 2021."}],"balance_after":146864,"source":{"system":"sec-edgar","filing":"0001387131-21-008439","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121008439/ownership.xml","form_type":"4"}},{"id":2646987,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-07-02T22:02:30.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":99174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on July 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on July 1, 2022."}],"balance_after":99174,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":99174},"source":{"system":"sec-edgar","filing":"0001387131-21-007129","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121007129/ownership.xml","form_type":"4"}},{"id":2853958,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T22:16:39.000Z","date":"2021-02-13","kind":"exercise","acquired":false,"shares":2779.1458,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024."}],"balance_after":5694.57,"derivative":{"underlying":"Common Stock","underlying_shares":2779.1458},"source":{"system":"sec-edgar","filing":"0001555280-21-000120","document":"wf-form4_161360018202240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528021000120/wf-form4_161360018202240.xml","form_type":"4"}},{"id":2853957,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-17T22:16:39.000Z","date":"2021-02-13","kind":"exercise","acquired":true,"shares":2779,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."}],"balance_after":14527,"source":{"system":"sec-edgar","filing":"0001555280-21-000120","document":"wf-form4_161360018202240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528021000120/wf-form4_161360018202240.xml","form_type":"4"}},{"id":2862785,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-02-12T22:47:50.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":1431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The RSUs vest as follows: 2,779.1458 RSUs will vest on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024."}],"balance_after":8473.7158,"derivative":{"underlying":"Common Stock","underlying_shares":1431},"source":{"system":"sec-edgar","filing":"0001555280-21-000071","document":"wf-form4_161317004477953.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528021000071/wf-form4_161317004477953.xml","form_type":"4"}},{"id":3104966,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-19T21:11:49.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":96864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021."}],"balance_after":96864,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":96864},"source":{"system":"sec-edgar","filing":"0001387131-20-005822","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713120005822/ownership.xml","form_type":"4"}},{"id":3119721,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T20:10:11.000Z","date":"2020-06-04","kind":"purchase","acquired":true,"shares":50000,"price":1.14,"value":57000.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001387131-20-005523","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713120005523/ownership.xml","form_type":"4"}},{"id":3262574,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-02-19T22:22:28.000Z","date":"2020-02-14","kind":"exercise","acquired":false,"shares":3704.6976,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,704.6976 RSUs vested on February 14, 2020; 2,763.4058 RSUs will vest on February 13, 2021; 2,643.4229 RSUs will vest on February 12, 2022; and 1,596 RSUs will vest on February 11, 2023."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,704.6976 RSUs vested on February 14, 2020; 2,763.4058 RSUs will vest on February 13, 2021; 2,643.4229 RSUs will vest on February 12, 2022; and 1,596 RSUs will vest on February 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,704.6976 RSUs vested on February 14, 2020; 2,763.4058 RSUs will vest on February 13, 2021; 2,643.4229 RSUs will vest on February 12, 2022; and 1,596 RSUs will vest on February 11, 2023."}],"balance_after":7002.8287,"derivative":{"underlying":"Common Stock","underlying_shares":3704.6976},"source":{"system":"sec-edgar","filing":"0001555280-20-000116","document":"wf-form4_158215093098281.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528020000116/wf-form4_158215093098281.xml","form_type":"4"}},{"id":3262573,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-19T22:22:28.000Z","date":"2020-02-14","kind":"exercise","acquired":true,"shares":3704,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."}],"balance_after":11748,"source":{"system":"sec-edgar","filing":"0001555280-20-000116","document":"wf-form4_158215093098281.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528020000116/wf-form4_158215093098281.xml","form_type":"4"}},{"id":3273636,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-02-13T21:27:19.000Z","date":"2020-02-11","kind":"grant","acquired":true,"shares":1596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The RSUs vest as follows: 3,704.6976 RSUs will vest on February 14, 2020; 2,763.4058 RSUs will vest on February 13, 2021; 2,643.4229 RSUs will vest on February 12, 2022; and 1,596 RSUs will vest on February 11, 2023."}],"balance_after":10707.5263,"derivative":{"underlying":"Common Stock","underlying_shares":1596},"source":{"system":"sec-edgar","filing":"0001555280-20-000055","document":"wf-form4_158162922268531.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528020000055/wf-form4_158162922268531.xml","form_type":"4"}},{"id":3533707,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2019-05-09T21:43:58.000Z","date":"2019-05-07","kind":"exercise","acquired":false,"shares":24983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 99,933 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.  The restricted stock units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 99,933 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.  The restricted stock units do not expire."}],"balance_after":74950,"derivative":{"underlying":"Class A Common Stock","underlying_shares":24983},"source":{"system":"sec-edgar","filing":"0001723128-19-000089","document":"wf-form4_155743822355516.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000089/wf-form4_155743822355516.xml","form_type":"4"}},{"id":3533706,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2019-05-09T21:43:58.000Z","date":"2019-05-07","kind":"tax_withholding","acquired":false,"shares":12529,"price":13.44,"value":168389.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":29454,"source":{"system":"sec-edgar","filing":"0001723128-19-000089","document":"wf-form4_155743822355516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000089/wf-form4_155743822355516.xml","form_type":"4"}},{"id":3533705,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2019-05-09T21:43:58.000Z","date":"2019-05-07","kind":"exercise","acquired":true,"shares":24983,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":41983,"source":{"system":"sec-edgar","filing":"0001723128-19-000089","document":"wf-form4_155743822355516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000089/wf-form4_155743822355516.xml","form_type":"4"}},{"id":3599512,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2019-03-12T20:45:48.000Z","date":"2019-03-12","kind":"purchase","acquired":true,"shares":17000,"price":11.97,"value":203490.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $11.95 per share to $11.98 per share.  The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":17000,"source":{"system":"sec-edgar","filing":"0001723128-19-000040","document":"wf-form4_155242353408413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000040/wf-form4_155242353408413.xml","form_type":"4"}},{"id":3613228,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2019-03-05T22:58:29.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":86420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2020."}],"balance_after":86420,"derivative":{"underlying":"Class A Common Stock","underlying_shares":86420},"source":{"system":"sec-edgar","filing":"0001723128-19-000033","document":"wf-form4_155182669569421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000033/wf-form4_155182669569421.xml","form_type":"4"}},{"id":3613227,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option","published_at":"2019-03-05T22:58:29.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":175968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on March 1, 2020."}],"balance_after":175968,"derivative":{"exercise_price":13.5,"expiration_date":"2029-03-01","underlying":"Class A Common Stock","underlying_shares":175968},"source":{"system":"sec-edgar","filing":"0001723128-19-000033","document":"wf-form4_155182669569421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000033/wf-form4_155182669569421.xml","form_type":"4"}},{"id":3641458,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-02-21T22:09:18.000Z","date":"2019-02-19","kind":"exercise","acquired":false,"shares":4150.3887,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 4,150.3887 RSUs vested on February 19, 2019; 3,683.0826 RSUs will vest on February 14, 2020; 2,747.2827 RSUs will vest on February 13, 2021; and 2,628.0000 RSUs will vest on February 12, 2022."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 4,150.3887 RSUs vested on February 19, 2019; 3,683.0826 RSUs will vest on February 14, 2020; 2,747.2827 RSUs will vest on February 13, 2021; and 2,628.0000 RSUs will vest on February 12, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 4,150.3887 RSUs vested on February 19, 2019; 3,683.0826 RSUs will vest on February 14, 2020; 2,747.2827 RSUs will vest on February 13, 2021; and 2,628.0000 RSUs will vest on February 12, 2022."}],"balance_after":9058.3653,"derivative":{"underlying":"Common Stock","underlying_shares":4150.3887},"source":{"system":"sec-edgar","filing":"0001555280-19-000100","document":"wf-form4_155078694408806.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528019000100/wf-form4_155078694408806.xml","form_type":"4"}},{"id":3641457,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-21T22:09:18.000Z","date":"2019-02-19","kind":"exercise","acquired":true,"shares":4150,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."}],"balance_after":8044,"source":{"system":"sec-edgar","filing":"0001555280-19-000100","document":"wf-form4_155078694408806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528019000100/wf-form4_155078694408806.xml","form_type":"4"}},{"id":3656200,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-02-14T23:45:56.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":2628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The RSUs vest as follows: 4,150.3887 RSUs will vest on February 19, 2019; 3,683.0826 RSUs will vest on February 14, 2020; 2,747.2827 RSUs will vest on February 13, 2021; and 2,628.0000 RSUs will vest on February 12, 2022."}],"balance_after":13208.754,"derivative":{"underlying":"Common Stock","underlying_shares":2628},"source":{"system":"sec-edgar","filing":"0001555280-19-000042","document":"wf-form4_155018794265307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528019000042/wf-form4_155018794265307.xml","form_type":"4"}},{"id":3942714,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-08T23:22:22.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":99933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date."}],"balance_after":99933,"derivative":{"underlying":"Class A Common Stock","underlying_shares":99933},"source":{"system":"sec-edgar","filing":"0000899243-18-011944","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011944/doc4.xml","form_type":"4"}},{"id":3942713,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-05-08T23:22:22.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":408719,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in four equal annual installments beginning on May 07, 2019."}],"balance_after":408719,"derivative":{"exercise_price":15.01,"expiration_date":"2028-05-07","underlying":"Class A Common Stock","underlying_shares":408719},"source":{"system":"sec-edgar","filing":"0000899243-18-011944","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011944/doc4.xml","form_type":"4"}},{"id":3942712,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-05-08T23:22:22.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":850000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received pursuant to the Business Combination Agreement, dated as of October 17, 2017, among Impax Laboratories, Inc. (\"Impax\"), Amneal Pharmaceuticals LLC, Atlas Holdings, Inc. and K2 Merger Sub Corporation in exchange for an option to purchase an equal number of shares of Impax common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is vested and currently exercisable."}],"balance_after":850000,"derivative":{"exercise_price":12.7,"expiration_date":"2027-03-27","underlying":"Class A Common Stock","underlying_shares":850000},"source":{"system":"sec-edgar","filing":"0000899243-18-011944","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011944/doc4.xml","form_type":"4"}},{"id":3943047,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:06:59.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":850000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Options disposed of pursuant to the terms of the Business Combination Agreement, dated as of October 17, 2017, by and among Impax Laboratories, Inc., Atlas Holdings, Inc. (\"Holdco\"), K2 Merger Sub Corporation and Amneal Pharmaceuticals LLC, as amended by Amendment No. 1, dated as of November 21, 2017, and Amendment No. 2, dated as of December 16, 2017 (the \"BCA\"), according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock of Holdco equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Options disposed of pursuant to the terms of the Business Combination Agreement, dated as of October 17, 2017, by and among Impax Laboratories, Inc., Atlas Holdings, Inc. (\"Holdco\"), K2 Merger Sub Corporation and Amneal Pharmaceuticals LLC, as amended by Amendment No. 1, dated as of November 21, 2017, and Amendment No. 2, dated as of December 16, 2017 (the \"BCA\"), according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock of Holdco equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options disposed of pursuant to the terms of the Business Combination Agreement, dated as of October 17, 2017, by and among Impax Laboratories, Inc., Atlas Holdings, Inc. (\"Holdco\"), K2 Merger Sub Corporation and Amneal Pharmaceuticals LLC, as amended by Amendment No. 1, dated as of November 21, 2017, and Amendment No. 2, dated as of December 16, 2017 (the \"BCA\"), according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock of Holdco equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":12.7,"expiration_date":"2027-03-27","underlying":"Common Stock","underlying_shares":850000},"source":{"system":"sec-edgar","filing":"0001003642-18-000077","document":"wf-form4_152581000589975.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000077/wf-form4_152581000589975.xml","form_type":"4"}},{"id":3945393,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2018-05-04T22:18:36.000Z","date":"2018-05-02","kind":"grant","acquired":true,"shares":1985,"price":151.07,"value":299873.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units shall vest 100% on the earlier of (i) the day before the 2019 Annual General Meeting of Shareholders and (ii) May 2, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":263729,"source":{"system":"sec-edgar","filing":"0001179110-18-006353","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000117911018006353/edgar.xml","form_type":"4"}},{"id":3947143,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-05-03T21:15:53.000Z","date":"2018-05-01","kind":"exercise","acquired":false,"shares":3894.6081,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,894.6081 RSUs vested on May 1, 2018; 4,130.3606 RSUs will vest on February 19, 2019; 3,665.3096 RSUs will vest on February 14, 2020; and 2,734.0255 RSUs will vest on February 13, 2021."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,894.6081 RSUs vested on May 1, 2018; 4,130.3606 RSUs will vest on February 19, 2019; 3,665.3096 RSUs will vest on February 14, 2020; and 2,734.0255 RSUs will vest on February 13, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,894.6081 RSUs vested on May 1, 2018; 4,130.3606 RSUs will vest on February 19, 2019; 3,665.3096 RSUs will vest on February 14, 2020; and 2,734.0255 RSUs will vest on February 13, 2021."}],"balance_after":10529.6957,"derivative":{"underlying":"Common Stock","underlying_shares":3894.6081},"source":{"system":"sec-edgar","filing":"0001555280-18-000174","document":"wf-form4_152538214000483.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528018000174/wf-form4_152538214000483.xml","form_type":"4"}},{"id":3947142,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-03T21:15:53.000Z","date":"2018-05-01","kind":"exercise","acquired":true,"shares":3894,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU."}],"balance_after":3894,"source":{"system":"sec-edgar","filing":"0001555280-18-000174","document":"wf-form4_152538214000483.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528018000174/wf-form4_152538214000483.xml","form_type":"4"}},{"id":3947141,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2018-05-03T13:55:15.000Z","date":"2018-05-01","kind":"tax_withholding","acquired":false,"shares":588,"price":152.94,"value":89928.72,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":261744,"source":{"system":"sec-edgar","filing":"0001179110-18-006107","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000117911018006107/edgar.xml","form_type":"4"}},{"id":4010434,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2018-03-06T23:51:09.000Z","date":"2018-03-05","kind":"tax_withholding","acquired":false,"shares":2921,"price":148.73,"value":434440.33,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":262332,"source":{"system":"sec-edgar","filing":"0001179110-18-003677","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000117911018003677/edgar.xml","form_type":"4"}},{"id":4054433,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-02-15T22:04:28.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":2730,"price":73.24,"value":199945.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The RSUs vest as follows: 3,888.8738 RSUs will vest on May 1, 2018; 4,124.2792 RSUs will vest on February 19, 2019; 3,659.9129 RSUs will vest on February 14, 2020; and 2,730 RSUs will vest on February 13, 2021."}],"balance_after":14403.0659,"derivative":{"underlying":"Common Stock","underlying_shares":2730},"source":{"system":"sec-edgar","filing":"0001555280-18-000065","document":"wf-form4_151873224243061.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528018000065/wf-form4_151873224243061.xml","form_type":"4"}},{"id":4116975,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2018-01-02T21:38:52.000Z","date":"2017-12-29","kind":"tax_withholding","acquired":false,"shares":6521,"price":163.58,"value":1066705.18,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":265253,"source":{"system":"sec-edgar","filing":"0001179110-18-000112","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000117911018000112/edgar.xml","form_type":"4"}},{"id":4178411,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance Based Restricted Share Unit","published_at":"2017-10-31T01:19:03.000Z","date":"2017-10-27","kind":"exercise","acquired":false,"shares":37727,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Performance Based Restricted Share Unit or PSU represented a contingent right to receive a number of Ordinary Shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Performance Based Restricted Share Unit or PSU represented a contingent right to receive a number of Ordinary Shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Performance Based Restricted Share Unit or PSU represented a contingent right to receive a number of Ordinary Shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Performance Based Restricted Share Unit or PSU represented a contingent right to receive a number of Ordinary Shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":37727},"source":{"system":"sec-edgar","filing":"0001179110-17-013548","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000117911017013548/edgar.xml","form_type":"4"}},{"id":4178410,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-10-31T01:19:03.000Z","date":"2017-10-26","kind":"exercise","acquired":true,"shares":37727,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are restricted share units, each of which represents a right to receive one ordinary share of Allergan plc. The restricted share units will vest in equal installments on each of December 31, 2017, December 31, 2018 and December 31, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Performance Based Restricted Share Unit or PSU represented a contingent right to receive a number of Ordinary Shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":271774,"source":{"system":"sec-edgar","filing":"0001179110-17-013548","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000117911017013548/edgar.xml","form_type":"4"}},{"id":4331557,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-05-05T22:26:02.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":1223,"price":245.25,"value":299940.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units shall vest 100% on the earlier of (i) the day before the 2018 Annual General Meeting of Shareholders or (ii) May 4, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":234047,"source":{"system":"sec-edgar","filing":"0001179110-17-006734","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000117911017006734/edgar.xml","form_type":"4"}},{"id":4331556,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-05-05T22:26:02.000Z","date":"2017-05-03","kind":"tax_withholding","acquired":false,"shares":214,"price":243.76,"value":52164.64,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":232824,"source":{"system":"sec-edgar","filing":"0001179110-17-006734","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000117911017006734/edgar.xml","form_type":"4"}},{"id":4361805,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2017-04-04T19:07:31.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":97.745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 5.918 phantom stock units accrued on January 27, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":3095.293,"derivative":{"exercise_price":121.49,"underlying":"Common Stock","underlying_shares":97.745},"source":{"system":"sec-edgar","filing":"0000911916-17-000143","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191617000143/edgar.xml","form_type":"4"}},{"id":4369589,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-29T18:20:01.000Z","date":"2017-03-27","kind":"grant","acquired":true,"shares":850000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal installments beginning on March 27, 2018, which is the first anniversary of the grant date."}],"balance_after":850000,"derivative":{"exercise_price":12.7,"expiration_date":"2027-03-27","underlying":"Common Stock","underlying_shares":850000},"source":{"system":"sec-edgar","filing":"0001003642-17-000029","document":"wf-form4_149082598118332.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364217000029/wf-form4_149082598118332.xml","form_type":"4"}},{"id":4397087,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-03-07T21:53:49.000Z","date":"2017-03-05","kind":"tax_withholding","acquired":false,"shares":2862,"price":245.63,"value":702993.06,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":233038,"source":{"system":"sec-edgar","filing":"0001179110-17-004107","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000117911017004107/edgar.xml","form_type":"4"}},{"id":4400082,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-03-06T11:59:38.000Z","date":"2017-03-02","kind":"sale","acquired":false,"shares":2371,"price":248.4,"value":588956.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $248.33 to $248.45, inclusive. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":235900,"source":{"system":"sec-edgar","filing":"0001179110-17-003930","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000117911017003930/edgar.xml","form_type":"4"}},{"id":4400081,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-03-06T11:59:38.000Z","date":"2017-03-02","kind":"sale","acquired":false,"shares":27688,"price":247.63,"value":6856379.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $247.22 to $248.21, inclusive. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent."}],"balance_after":238271,"source":{"system":"sec-edgar","filing":"0001179110-17-003930","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000117911017003930/edgar.xml","form_type":"4"}},{"id":4400080,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-03-06T11:59:38.000Z","date":"2017-03-02","kind":"sale","acquired":false,"shares":8267,"price":246.64,"value":2038972.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $246.21 to $247.02, inclusive. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent."}],"balance_after":265959,"source":{"system":"sec-edgar","filing":"0001179110-17-003930","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000117911017003930/edgar.xml","form_type":"4"}},{"id":4400079,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-03-06T11:59:38.000Z","date":"2017-03-02","kind":"sale","acquired":false,"shares":31674,"price":245.73,"value":7783252.02,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $245.21 to $246.17, inclusive. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":274226,"source":{"system":"sec-edgar","filing":"0001179110-17-003930","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000117911017003930/edgar.xml","form_type":"4"}},{"id":4442295,"issuer":{"id":679,"kind":"organization","name":"Zoetis Inc.","symbol":"ZTS"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-02-16T22:02:58.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":3635,"price":55.02,"value":199997.7,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an \"RSU\" and collectively, \"RSUs\"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The RSUs vest as follows: 3,862.4023 RSUs will vest on May 1, 2018; 4,096.2053 RSUs will vest on February 19, 2019; and 3,635 RSUs will vest on February 14, 2020."}],"balance_after":11593.6076,"derivative":{"underlying":"Common Stock","underlying_shares":3635},"source":{"system":"sec-edgar","filing":"0001555280-17-000055","document":"wf-form4_148728256539213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000155528017000055/wf-form4_148728256539213.xml","form_type":"4"}},{"id":4466128,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-02-07T01:09:19.000Z","date":"2017-02-02","kind":"grant","acquired":true,"shares":444,"price":229.52,"value":101906.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units shall vest 100% on the earlier of (i) the day before the 2017 Annual Shareholder Meeting or (ii) May 4, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":305900,"source":{"system":"sec-edgar","filing":"0001179110-17-001834","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000117911017001834/edgar.xml","form_type":"4"}},{"id":4466158,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-02-07T01:08:30.000Z","date":"2017-02-01","kind":"exercise","acquired":true,"shares":7105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents performance-based restricted share units (\"PSUs\") which vested on February 1, 2017, following certification of achievement by issuer of certain performance criteria. Each PSU represented a contingent right to receive ordinary shares of the Issuer equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents performance-based restricted share units (\"PSUs\") which vested on February 1, 2017, following certification of achievement by issuer of certain performance criteria. Each PSU represented a contingent right to receive ordinary shares of the Issuer equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":229.32,"exercise_date":"2017-02-01","expiration_date":"2017-02-01","underlying":"Ordinary Shares","underlying_shares":7105},"source":{"system":"sec-edgar","filing":"0001179110-17-001833","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000117911017001833/edgar.xml","form_type":"4/A","original_submission_date":"2017-02-03"}},{"id":4466157,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"BISARO PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-02-07T01:08:30.000Z","date":"2017-02-01","kind":"tax_withholding","acquired":false,"shares":3411,"price":229.32,"value":782210.52,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amendment to the Form 4 filed on February 3, 2017 is being filed in order to: (1) correct an administrative error whereby 120,000 ordinary shares, par value $0.0001 (the \"Ordinary Shares\"), were inadvertently excluded in the Reporting Person's direct ownership value and (2) properly reflect 120,000 shares held in Paul Bisaro LLC (\"LLC\"), an LLC in which Mr. Bisaro retains an ownership interest and might be deemed to have or share investment control."}],"balance_after":305456,"source":{"system":"sec-edgar","filing":"0001179110-17-001833","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237253/000117911017001833/edgar.xml","form_type":"4/A","original_submission_date":"2017-02-03"}}],"next_cursor":"2017-02-07T01:08:30.000000Z,4466157"}